300+ investors in your industry, stage, and region Get
Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Travel
Platforms
InsurTech
Enterprise Software
Oil and Gas
Retail
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Social Network
Blockchain
B2B
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Theatre
Medical
Recruiting
Web3
Venture Capital
Fashion
Social
Beauty
Infrastructure
Cannabis
LGBT
Celebrity
Climate
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Publishing
Music
Art
Real Estate
Sporting Goods
Manufacturing
Digital Media
FinTech
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Sustainability
Enterprise
Hardware
Biotech
Community
Impact
Media (Entertainment)
Proptech
Transportation
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Gibraltar
Africa
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Oceania
Romania
Poland
Oman
Puerto Rico
Sudan
Cameroon
Guernsey
Andorra
Colombia
Armenia
China
Costa Rica
Kenya
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Morocco
Moldova
Seychelles
Paraguay
Botswana
Japan
Ireland
Canada
United Kingdom
South Africa
France
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
Germany
India
United States
Indonesia
Middle East
Dominican Republic
Asia
Albania
Spain
Angola
Europe
Bermuda
Cyprus
Qatar
Argentina
Bangladesh
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Neil Mahapatra, Managing Partner at Kingsley Capital Partners

Neil Mahapatra

Managing Partner @ Kingsley Capital Partners

London, United Kingdom

Neil Mahapatra is a seed investor at Kingsley Capital Partners in London focused on Medical and Cannabis. Neil Mahapatra is the Founder and Managing Partner of Kingsley Capital Partners. He Previously worked at J. Rothschild Capital Management as a Private Equity Executive. Neil Mahapatra attended Harvard Business School.

Total investments:
5
Last investment:
Lead investor:
20%

Last updated:

Industries Neil Mahapatra invests in

MedicalCannabisBiotechnologyPharmaceutical

Stages Neil Mahapatra invests in

SeedFunding RoundPost-IPO Debt

Countries Neil Mahapatra invests in

United Kingdom

Investment Focus

Industry

  • Medical 1 (20%)
  • Cannabis 1 (20%)
  • Biotechnology 1 (20%)
  • Pharmaceutical 1 (20%)

Stage

  • Seed 3 (60%)
  • Funding Round 1 (20%)
  • Post-IPO Debt 1 (20%)

Investments

CompanyDescriptionRoundLinks
Oxford Cannabinoid Technologies Oxford Cannabinoid Technologies
Oxford Cannabinoid Technologies is a biopharmaceutical company established to combine cannabinoid medicine with world class scientific research and drug development. OCT brings together some of the world’s best medical researchers to develop new therapies for diseases with high unmet medical need. $713.8K / Post-IPO Debt / Feb 02, 2024
Spring Fibre
Seed
Atlas Tower Group Atlas Tower Group
Atlas Tower Group is a wireless infrastructure solution provider specialized in designing towers and rooftops that are 5G ready. Seed
Equinox International Equinox International
Equinox is a cannabis company focused on developing pharmaceutical quality products. Seed
Oxford Cannabinoid Technologies Oxford Cannabinoid Technologies
Oxford Cannabinoid Technologies is a biopharmaceutical company established to combine cannabinoid medicine with world class scientific research and drug development. OCT brings together some of the world’s best medical researchers to develop new therapies for diseases with high unmet medical need.

Co-Investors

Cantheon Capital 1 deal together
Kingsley Capital Partners

About Kingsley Capital Partners

VC Fund

Kingsley Capital Partners Contacts

NameEmailPhoneSocials
Neil Mahapatra
Neil Mahapatra Managing Partner

Sign up to unlock verified contacts

Unlock Contacts

4 more contacts available

Open Kingsley Capital Partners full profile

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Travel
Platforms
InsurTech
Enterprise Software
Oil and Gas
Retail
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Social Network
Blockchain
B2B
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Theatre
Medical
Recruiting
Web3
Venture Capital
Fashion
Social
Beauty
Infrastructure
Cannabis
LGBT
Celebrity
Climate
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Publishing
Music
Art
Real Estate
Sporting Goods
Manufacturing
Digital Media
FinTech
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Sustainability
Enterprise
Hardware
Biotech
Community
Impact
Media (Entertainment)
Proptech
Transportation
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Gibraltar
Africa
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Oceania
Romania
Poland
Oman
Puerto Rico
Sudan
Cameroon
Guernsey
Andorra
Colombia
Armenia
China
Costa Rica
Kenya
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Morocco
Moldova
Seychelles
Paraguay
Botswana
Japan
Ireland
Canada
United Kingdom
South Africa
France
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
Germany
India
United States
Indonesia
Middle East
Dominican Republic
Asia
Albania
Spain
Angola
Europe
Bermuda
Cyprus
Qatar
Argentina
Bangladesh
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Neil Mahapatra invest in?

Neil Mahapatra invests primarily in Medical, Cannabis and Biotechnology startups, most often at Seed and Funding Round stage. Most of the 5 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.

When did Neil Mahapatra last invest?

The most recent investment recorded for Neil Mahapatra closed in Feb 2024. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Neil Mahapatra Neil Mahapatra Find email